Indaptus Therapeutics, Inc.
INDP· Nasdaq
Released Aug 13, 2025, before the open
10-Q filed Aug 13, 2025, 44 days after period end · 0001641172-25-023333
| Metric | Q2 2025 | Q2 2024 | Q2 2023 | Q2 2022 |
|---|---|---|---|---|
| Net Income | -$5.23M | -$4.02M | -$3.25M | -$3.84M |
| EPS Diluted | -$9.09 | -$13.16 | -$0.39 | -$0.46 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Indaptus Therapeutics, Inc. · CIK 1857044 · Engraved from SEC EDGAR